Key result
Low-dose adenosine infusion improved regional left ventricular systolic function in ischemic walls during dobutamine stress without affecting coronary flow reserve.
Why the study?
Does intravenous low-dose adenosine reduce the ischemic burden induced by pharmacological stress in patients with advanced coronary artery disease?
RCT (n=11)
double-blind
cross-over
Does intravenous low-dose adenosine reduce the ischemic burden induced by pharmacological stress in patients with advanced coronary artery disease?
Low-dose adenosine infusion improves regional LV systolic function in ischemic walls during stress without affecting coronary flow reserve, suggesting an ischemic preconditioning effect.
Supports adjunctive low-dose adenosine to lessen stress-induced ischemia in CAD; extends preconditioning evidence to regional LV recovery.
BACKGROUND: Adenosine plays a key role in different protective and adaptive responses to ischemia and has been suggested to induce ischemic preconditioning. AIM: To investigate whether a low-dose adenosine infusion reduces the ischemic burden induced by pharmacological stress without affecting the coronary flow reserve (CFR). MATERIALS AND METHODS: Myocardial ischemia was induced by dobutamine stress test and quantified by tissue Doppler echocardiography in 11 patients with advanced coronary artery disease. CFR was quantified during high-dose adenosine infusion by contrast echocardiography. Before the dobutamine stress test and contrast echocardiography, intravenous low-dose adenosine or placebo was infused over 15 min according to a randomized, double-blind, cross-over protocol. Echocardiographic left ventricular (LV) apical images and flow pattern of left anterior descending coronary artery (LAD) were obtained at baseline, during adenosine/placebo infusion, maximal, and recovery phases.Furthermore, the LV walls were categorized as ischemic or nonischemic according to a predefined ischemic threshold of at least 25% increment in peak systolic velocity (PSV)from baseline to maximal stress. CFR was measured as the ratio of peak/baseline of maximal diastolic velocity in the distal LAD. RESULTS: PSV increased both during placebo and adenosine infusions from baseline to maximal stress. However, in the ischemic walls, the PSV increased only during adenosine infusion, whereas no differences were observed in the nonischemic walls. There were no differences in blood pressure, heart rate, or regional CFR during placebo or adenosine infusion. CONCLUSION: Low-dose adenosine infusion improves regional LV systolic function in the ischemic walls, without any effect on CFR, suggesting that the observed improvement may be because of ischemic preconditioning.
No takes yet. Share an insight, caveat, or question.
Sadigh et al. (2009) conducted an RCT in advanced coronary artery disease (n=11). Low-dose adenosine vs. placebo was evaluated on Peak systolic velocity (PSV) and coronary flow reserve (CFR). Low-dose adenosine infusion improved regional left ventricular systolic function in ischemic walls during dobutamine stress without affecting coronary flow reserve.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: